Ethyl 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-carboxylate | 113805-74-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噁庚英
• 英文名称: Ethyl 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-carboxylate
• 英文别名: ethyl (11E)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepine-2-carboxylate
• CAS: 113805-74-6
• 化学式: C₂₂H₂₅NO₃
• 分子量: 351.445
• InChiKey: PLYHBXQNZFOMPP-VXLYETTFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  26
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  (E)-11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz[b,e]oxepin-2-carboxylic acid 在 硫酸 作用下， 以 乙醇 、 水 为溶剂， 生成 Ethyl 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-carboxylate
  参考文献：
  名称：

  Dibenz[b,e]oxepin derivative and pharmaceutical compositions thereof

  摘要：

  新颖的二苯并[b,e]噁啶衍生物被用于治疗和控制过敏症状，如过敏性哮喘，并且也被用于治疗炎症。

  公开号：

  US05116863A1

文献信息

• USE OF CONNECTIVE TISSUE MAST CELL STABILIZERS TO FACILITATE OCULAR SURFACE RE-EPITHELIZATION AND WOUND REPAIR
  申请人：Yanni John M.

  公开号：US20080139531A1

  公开（公告）日：2008-06-12

  Disclosed are methods of treating a wound in a subject that involve administering to the subject a pharmaceutically effective amount of a composition that includes one or more human connective tissue mast cell stabilizers, wherein administration of the composition results in treatment of the wound. In particular embodiments, the wound is an ophthalmic or dermal wound, such as a corneal epithelial defect, a conjunctival wound, or dermal abrasion. Administration, for example, may be by topical application of the composition to the ocular surface or skin. Exemplary mast cell stabilizers include olopatadine, variants of olopatadine, alcaftidine, derivatives of alcaftidine, dihydropyridines, and spleen tyrosine kinase inhibitors.
• US5116863A
  申请人：——

  公开号：US5116863A

  公开（公告）日：1992-05-26
• Dibenz[b,e]oxepin derivative and pharmaceutical compositions thereof
  申请人：Kyowa Hakko Kogyo Co., Ltd.

  公开号：US05116863A1

  公开（公告）日：1992-05-26

  Novel dibenz[b,e]oxepin derivatives are employed in the treatment and control of allergic conditions such as allergic asthma and also employed in the treatment of inflammation.

  新颖的二苯并[b,e]噁啶衍生物被用于治疗和控制过敏症状，如过敏性哮喘，并且也被用于治疗炎症。